aluates Reports

$ 0.0

Automative

Global Seasonal Affective Disorder Therapeutics Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-34L14446

Global Seasonal Affective Disorder Therapeutics Market Insights Forecast to 2029

BUY CHAPTERS

Global Seasonal Affective Disorder Therapeutics Market Insights, Forecast to 2030

Code: QYRE-Auto-34L14446

Report

December 2024

Pages:107

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Allergan plc

Pfizer Inc

Roche

Eli Lily

GlaxoSmithKline PLC

Teva Pharmaceuticals

Bausch Health Companies

Mylan NV

Sanofi

Novartis

Johnson & Johnson

Koninklijke Philips

Beurer

Lucimed (Luminette)

Seasonal Affective Disorder Therapeutics Market

Seasonal affective disorder (SAD) is a mood disorder subset in which people who have normal mental health throughout most of the year exhibit depressive symptoms at the same time each year, most commonly in the winter. Common symptoms include sleeping too much, having little to no energy, and overeating. The condition in the summer can include heightened anxiety.

Market Analysis and Insights: Global Seasonal Affective Disorder Therapeutics Market

The global Seasonal Affective Disorder Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Seasonal Affective Disorder Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Seasonal Affective Disorder Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Seasonal Affective Disorder Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Seasonal Affective Disorder Therapeutics include Allergan, Pfizer, Roche, Eli Lily, GlaxoSmithKline, Teva Pharmaceuticals, Bausch Health Companies, Mylan and Sanofi, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Seasonal Affective Disorder Therapeutics is widely used in various fields, such as Hospitals, Clinics and Others,, etc. Hospitals provides greatest supports to the Seasonal Affective Disorder Therapeutics industry development. In 2023, global % revenue of Seasonal Affective Disorder Therapeutics went into Hospitals filed and the proportion will reach to % in 2030.

Report Covers:

This report presents an overview of global market for Seasonal Affective Disorder Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Seasonal Affective Disorder Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Seasonal Affective Disorder Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Seasonal Affective Disorder Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Seasonal Affective Disorder Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Seasonal Affective Disorder Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Seasonal Affective Disorder Therapeutics Market Report

Report Metric	Details
Report Name	Seasonal Affective Disorder Therapeutics Market
Segment by Type	Light Therapy (Phototherapy) Medication Others
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Allergan, Pfizer, Roche, Eli Lily, GlaxoSmithKline, Teva Pharmaceuticals, Bausch Health Companies, Mylan, Sanofi, Novartis, Johnson & Johnson, Koninklijke Philips, Beurer GmbH, Lucimed (Luminette)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Seasonal Affective Disorder Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Seasonal Affective Disorder Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Seasonal Affective Disorder Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Seasonal Affective Disorder Therapeutics Market report?

Ans: The main players in the Seasonal Affective Disorder Therapeutics Market are Allergan, Pfizer, Roche, Eli Lily, GlaxoSmithKline, Teva Pharmaceuticals, Bausch Health Companies, Mylan, Sanofi, Novartis, Johnson & Johnson, Koninklijke Philips, Beurer GmbH, Lucimed (Luminette)

What are the Application segmentation covered in the Seasonal Affective Disorder Therapeutics Market report?

Ans: The Applications covered in the Seasonal Affective Disorder Therapeutics Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Seasonal Affective Disorder Therapeutics Market report?

Ans: The Types covered in the Seasonal Affective Disorder Therapeutics Market report are Light Therapy (Phototherapy), Medication, Others

Recommended Reports

Mental Health Therapeutics

Depression and Related

Neurologic & Syndrome Treatments

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Seasonal Affective Disorder Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Light Therapy (Phototherapy)

1.2.3 Medication

1.2.4 Others

1.3 Market by Application

1.3.1 Global Seasonal Affective Disorder Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Seasonal Affective Disorder Therapeutics Market Perspective (2019-2030)

2.2 Global Seasonal Affective Disorder Therapeutics Growth Trends by Region

2.2.1 Seasonal Affective Disorder Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Seasonal Affective Disorder Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Seasonal Affective Disorder Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Seasonal Affective Disorder Therapeutics Market Dynamics

2.3.1 Seasonal Affective Disorder Therapeutics Industry Trends

2.3.2 Seasonal Affective Disorder Therapeutics Market Drivers

2.3.3 Seasonal Affective Disorder Therapeutics Market Challenges

2.3.4 Seasonal Affective Disorder Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Seasonal Affective Disorder Therapeutics by Players

3.1.1 Global Seasonal Affective Disorder Therapeutics Revenue by Players (2019-2024)

3.1.2 Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Seasonal Affective Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Seasonal Affective Disorder Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Seasonal Affective Disorder Therapeutics Market Concentration Ratio

3.4.1 Global Seasonal Affective Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Seasonal Affective Disorder Therapeutics Revenue in 2023

3.5 Global Key Players of Seasonal Affective Disorder Therapeutics Head office and Area Served

3.6 Global Key Players of Seasonal Affective Disorder Therapeutics, Product and Application

3.7 Global Key Players of Seasonal Affective Disorder Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Seasonal Affective Disorder Therapeutics Breakdown Data by Type

4.1 Global Seasonal Affective Disorder Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Seasonal Affective Disorder Therapeutics Forecasted Market Size by Type (2025-2030)

5 Seasonal Affective Disorder Therapeutics Breakdown Data by Application

5.1 Global Seasonal Affective Disorder Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Seasonal Affective Disorder Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Seasonal Affective Disorder Therapeutics Market Size (2019-2030)

6.2 North America Seasonal Affective Disorder Therapeutics Market Size by Type

6.2.1 North America Seasonal Affective Disorder Therapeutics Market Size by Type (2019-2024)

6.2.2 North America Seasonal Affective Disorder Therapeutics Market Size by Type (2025-2030)

6.2.3 North America Seasonal Affective Disorder Therapeutics Market Share by Type (2019-2030)

6.3 North America Seasonal Affective Disorder Therapeutics Market Size by Application

6.3.1 North America Seasonal Affective Disorder Therapeutics Market Size by Application (2019-2024)

6.3.2 North America Seasonal Affective Disorder Therapeutics Market Size by Application (2025-2030)

6.3.3 North America Seasonal Affective Disorder Therapeutics Market Share by Application (2019-2030)

6.4 North America Seasonal Affective Disorder Therapeutics Market Size by Country

6.4.1 North America Seasonal Affective Disorder Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Seasonal Affective Disorder Therapeutics Market Size by Country (2019-2024)

6.4.3 North America Seasonal Affective Disorder Therapeutics Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Seasonal Affective Disorder Therapeutics Market Size (2019-2030)

7.2 Europe Seasonal Affective Disorder Therapeutics Market Size by Type

7.2.1 Europe Seasonal Affective Disorder Therapeutics Market Size by Type (2019-2024)

7.2.2 Europe Seasonal Affective Disorder Therapeutics Market Size by Type (2025-2030)

7.2.3 Europe Seasonal Affective Disorder Therapeutics Market Share by Type (2019-2030)

7.3 Europe Seasonal Affective Disorder Therapeutics Market Size by Application

7.3.1 Europe Seasonal Affective Disorder Therapeutics Market Size by Application (2019-2024)

7.3.2 Europe Seasonal Affective Disorder Therapeutics Market Size by Application (2025-2030)

7.3.3 Europe Seasonal Affective Disorder Therapeutics Market Share by Application (2019-2030)

7.4 Europe Seasonal Affective Disorder Therapeutics Market Size by Country

7.4.1 Europe Seasonal Affective Disorder Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Seasonal Affective Disorder Therapeutics Market Size by Country (2019-2024)

7.4.3 Europe Seasonal Affective Disorder Therapeutics Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Seasonal Affective Disorder Therapeutics Market Size (2019-2030)

8.2 China Seasonal Affective Disorder Therapeutics Market Size by Type

8.2.1 China Seasonal Affective Disorder Therapeutics Market Size by Type (2019-2024)

8.2.2 China Seasonal Affective Disorder Therapeutics Market Size by Type (2025-2030)

8.2.3 China Seasonal Affective Disorder Therapeutics Market Share by Type (2019-2030)

8.3 China Seasonal Affective Disorder Therapeutics Market Size by Application

8.3.1 China Seasonal Affective Disorder Therapeutics Market Size by Application (2019-2024)

8.3.2 China Seasonal Affective Disorder Therapeutics Market Size by Application (2025-2030)

8.3.3 China Seasonal Affective Disorder Therapeutics Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Seasonal Affective Disorder Therapeutics Market Size (2019-2030)

9.2 Asia Seasonal Affective Disorder Therapeutics Market Size by Type

9.2.1 Asia Seasonal Affective Disorder Therapeutics Market Size by Type (2019-2024)

9.2.2 Asia Seasonal Affective Disorder Therapeutics Market Size by Type (2025-2030)

9.2.3 Asia Seasonal Affective Disorder Therapeutics Market Share by Type (2019-2030)

9.3 Asia Seasonal Affective Disorder Therapeutics Market Size by Application

9.3.1 Asia Seasonal Affective Disorder Therapeutics Market Size by Application (2019-2024)

9.3.2 Asia Seasonal Affective Disorder Therapeutics Market Size by Application (2025-2030)

9.3.3 Asia Seasonal Affective Disorder Therapeutics Market Share by Application (2019-2030)

9.4 Asia Seasonal Affective Disorder Therapeutics Market Size by Region

9.4.1 Asia Seasonal Affective Disorder Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Seasonal Affective Disorder Therapeutics Market Size by Region (2019-2024)

9.4.3 Asia Seasonal Affective Disorder Therapeutics Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Seasonal Affective Disorder Therapeutics Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Seasonal Affective Disorder Therapeutics Market Size by Type

10.2.1 Middle East, Africa, and Latin America Seasonal Affective Disorder Therapeutics Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Seasonal Affective Disorder Therapeutics Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Seasonal Affective Disorder Therapeutics Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Seasonal Affective Disorder Therapeutics Market Size by Application

10.3.1 Middle East, Africa, and Latin America Seasonal Affective Disorder Therapeutics Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Seasonal Affective Disorder Therapeutics Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Seasonal Affective Disorder Therapeutics Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Seasonal Affective Disorder Therapeutics Market Size by Country

10.4.1 Middle East, Africa, and Latin America Seasonal Affective Disorder Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Seasonal Affective Disorder Therapeutics Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Seasonal Affective Disorder Therapeutics Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Allergan

11.1.1 Allergan Company Details

11.1.2 Allergan Business Overview

11.1.3 Allergan Seasonal Affective Disorder Therapeutics Introduction

11.1.4 Allergan Revenue in Seasonal Affective Disorder Therapeutics Business (2019-2024)

11.1.5 Allergan Recent Developments

11.2 Pfizer

11.2.1 Pfizer Company Details

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Seasonal Affective Disorder Therapeutics Introduction

11.2.4 Pfizer Revenue in Seasonal Affective Disorder Therapeutics Business (2019-2024)

11.2.5 Pfizer Recent Developments

11.3 Roche

11.3.1 Roche Company Details

11.3.2 Roche Business Overview

11.3.3 Roche Seasonal Affective Disorder Therapeutics Introduction

11.3.4 Roche Revenue in Seasonal Affective Disorder Therapeutics Business (2019-2024)

11.3.5 Roche Recent Developments

11.4 Eli Lily

11.4.1 Eli Lily Company Details

11.4.2 Eli Lily Business Overview

11.4.3 Eli Lily Seasonal Affective Disorder Therapeutics Introduction

11.4.4 Eli Lily Revenue in Seasonal Affective Disorder Therapeutics Business (2019-2024)

11.4.5 Eli Lily Recent Developments

11.5 GlaxoSmithKline

11.5.1 GlaxoSmithKline Company Details

11.5.2 GlaxoSmithKline Business Overview

11.5.3 GlaxoSmithKline Seasonal Affective Disorder Therapeutics Introduction

11.5.4 GlaxoSmithKline Revenue in Seasonal Affective Disorder Therapeutics Business (2019-2024)

11.5.5 GlaxoSmithKline Recent Developments

11.6 Teva Pharmaceuticals

11.6.1 Teva Pharmaceuticals Company Details

11.6.2 Teva Pharmaceuticals Business Overview

11.6.3 Teva Pharmaceuticals Seasonal Affective Disorder Therapeutics Introduction

11.6.4 Teva Pharmaceuticals Revenue in Seasonal Affective Disorder Therapeutics Business (2019-2024)

11.6.5 Teva Pharmaceuticals Recent Developments

11.7 Bausch Health Companies

11.7.1 Bausch Health Companies Company Details

11.7.2 Bausch Health Companies Business Overview

11.7.3 Bausch Health Companies Seasonal Affective Disorder Therapeutics Introduction

11.7.4 Bausch Health Companies Revenue in Seasonal Affective Disorder Therapeutics Business (2019-2024)

11.7.5 Bausch Health Companies Recent Developments

11.8 Mylan

11.8.1 Mylan Company Details

11.8.2 Mylan Business Overview

11.8.3 Mylan Seasonal Affective Disorder Therapeutics Introduction

11.8.4 Mylan Revenue in Seasonal Affective Disorder Therapeutics Business (2019-2024)

11.8.5 Mylan Recent Developments

11.9 Sanofi

11.9.1 Sanofi Company Details

11.9.2 Sanofi Business Overview

11.9.3 Sanofi Seasonal Affective Disorder Therapeutics Introduction

11.9.4 Sanofi Revenue in Seasonal Affective Disorder Therapeutics Business (2019-2024)

11.9.5 Sanofi Recent Developments

11.10 Novartis

11.10.1 Novartis Company Details

11.10.2 Novartis Business Overview

11.10.3 Novartis Seasonal Affective Disorder Therapeutics Introduction

11.10.4 Novartis Revenue in Seasonal Affective Disorder Therapeutics Business (2019-2024)

11.10.5 Novartis Recent Developments

11.11 Johnson & Johnson

11.11.1 Johnson & Johnson Company Details

11.11.2 Johnson & Johnson Business Overview

11.11.3 Johnson & Johnson Seasonal Affective Disorder Therapeutics Introduction

11.11.4 Johnson & Johnson Revenue in Seasonal Affective Disorder Therapeutics Business (2019-2024)

11.11.5 Johnson & Johnson Recent Developments

11.12 Koninklijke Philips

11.12.1 Koninklijke Philips Company Details

11.12.2 Koninklijke Philips Business Overview

11.12.3 Koninklijke Philips Seasonal Affective Disorder Therapeutics Introduction

11.12.4 Koninklijke Philips Revenue in Seasonal Affective Disorder Therapeutics Business (2019-2024)

11.12.5 Koninklijke Philips Recent Developments

11.13 Beurer GmbH

11.13.1 Beurer GmbH Company Details

11.13.2 Beurer GmbH Business Overview

11.13.3 Beurer GmbH Seasonal Affective Disorder Therapeutics Introduction

11.13.4 Beurer GmbH Revenue in Seasonal Affective Disorder Therapeutics Business (2019-2024)

11.13.5 Beurer GmbH Recent Developments

11.14 Lucimed (Luminette)

11.14.1 Lucimed (Luminette) Company Details

11.14.2 Lucimed (Luminette) Business Overview

11.14.3 Lucimed (Luminette) Seasonal Affective Disorder Therapeutics Introduction

11.14.4 Lucimed (Luminette) Revenue in Seasonal Affective Disorder Therapeutics Business (2019-2024)

11.14.5 Lucimed (Luminette) Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Allergan plc

Pfizer Inc

Roche

Eli Lily

GlaxoSmithKline PLC

Teva Pharmaceuticals

Bausch Health Companies

Mylan NV

Sanofi

Novartis

Johnson & Johnson

Koninklijke Philips

Beurer

Lucimed (Luminette)

List of Tables

Table 1. Global Seasonal Affective Disorder Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Light Therapy (Phototherapy)

Table 3. Key Players of Medication

Table 4. Key Players of Others

Table 5. Global Seasonal Affective Disorder Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 6. Global Seasonal Affective Disorder Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Seasonal Affective Disorder Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Seasonal Affective Disorder Therapeutics Market Share by Region (2019-2024)

Table 9. Global Seasonal Affective Disorder Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Seasonal Affective Disorder Therapeutics Market Share by Region (2025-2030)

Table 11. Seasonal Affective Disorder Therapeutics Market Trends

Table 12. Seasonal Affective Disorder Therapeutics Market Drivers

Table 13. Seasonal Affective Disorder Therapeutics Market Challenges

Table 14. Seasonal Affective Disorder Therapeutics Market Restraints

Table 15. Global Seasonal Affective Disorder Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Seasonal Affective Disorder Therapeutics Revenue Share by Players (2019-2024)

Table 17. Global Top Seasonal Affective Disorder Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Seasonal Affective Disorder Therapeutics as of 2023)

Table 18. Global Seasonal Affective Disorder Therapeutics Industry Ranking 2022 VS 2023 VS 2024

Table 19. Global 5 Largest Players Market Share by Seasonal Affective Disorder Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Seasonal Affective Disorder Therapeutics, Headquarters and Area Served

Table 21. Global Key Players of Seasonal Affective Disorder Therapeutics, Product and Application

Table 22. Global Key Players of Seasonal Affective Disorder Therapeutics, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Seasonal Affective Disorder Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Type (2019-2024)

Table 26. Global Seasonal Affective Disorder Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Type (2025-2030)

Table 28. Global Seasonal Affective Disorder Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Seasonal Affective Disorder Therapeutics Revenue Share by Application (2019-2024)

Table 30. Global Seasonal Affective Disorder Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Seasonal Affective Disorder Therapeutics Revenue Share by Application (2025-2030)

Table 32. North America Seasonal Affective Disorder Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America Seasonal Affective Disorder Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America Seasonal Affective Disorder Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America Seasonal Affective Disorder Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America Seasonal Affective Disorder Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Seasonal Affective Disorder Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Seasonal Affective Disorder Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Seasonal Affective Disorder Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe Seasonal Affective Disorder Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe Seasonal Affective Disorder Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe Seasonal Affective Disorder Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe Seasonal Affective Disorder Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe Seasonal Affective Disorder Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe Seasonal Affective Disorder Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 46. China Seasonal Affective Disorder Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 47. China Seasonal Affective Disorder Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 48. China Seasonal Affective Disorder Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 49. China Seasonal Affective Disorder Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia Seasonal Affective Disorder Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia Seasonal Affective Disorder Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia Seasonal Affective Disorder Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia Seasonal Affective Disorder Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Seasonal Affective Disorder Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia Seasonal Affective Disorder Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia Seasonal Affective Disorder Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Seasonal Affective Disorder Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Seasonal Affective Disorder Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Seasonal Affective Disorder Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Seasonal Affective Disorder Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Seasonal Affective Disorder Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America Seasonal Affective Disorder Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Seasonal Affective Disorder Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 64. Allergan Company Details

Table 65. Allergan Business Overview

Table 66. Allergan Seasonal Affective Disorder Therapeutics Product

Table 67. Allergan Revenue in Seasonal Affective Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 68. Allergan Recent Developments

Table 69. Pfizer Company Details

Table 70. Pfizer Business Overview

Table 71. Pfizer Seasonal Affective Disorder Therapeutics Product

Table 72. Pfizer Revenue in Seasonal Affective Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 73. Pfizer Recent Developments

Table 74. Roche Company Details

Table 75. Roche Business Overview

Table 76. Roche Seasonal Affective Disorder Therapeutics Product

Table 77. Roche Revenue in Seasonal Affective Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 78. Roche Recent Developments

Table 79. Eli Lily Company Details

Table 80. Eli Lily Business Overview

Table 81. Eli Lily Seasonal Affective Disorder Therapeutics Product

Table 82. Eli Lily Revenue in Seasonal Affective Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 83. Eli Lily Recent Developments

Table 84. GlaxoSmithKline Company Details

Table 85. GlaxoSmithKline Business Overview

Table 86. GlaxoSmithKline Seasonal Affective Disorder Therapeutics Product

Table 87. GlaxoSmithKline Revenue in Seasonal Affective Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 88. GlaxoSmithKline Recent Developments

Table 89. Teva Pharmaceuticals Company Details

Table 90. Teva Pharmaceuticals Business Overview

Table 91. Teva Pharmaceuticals Seasonal Affective Disorder Therapeutics Product

Table 92. Teva Pharmaceuticals Revenue in Seasonal Affective Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 93. Teva Pharmaceuticals Recent Developments

Table 94. Bausch Health Companies Company Details

Table 95. Bausch Health Companies Business Overview

Table 96. Bausch Health Companies Seasonal Affective Disorder Therapeutics Product

Table 97. Bausch Health Companies Revenue in Seasonal Affective Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 98. Bausch Health Companies Recent Developments

Table 99. Mylan Company Details

Table 100. Mylan Business Overview

Table 101. Mylan Seasonal Affective Disorder Therapeutics Product

Table 102. Mylan Revenue in Seasonal Affective Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 103. Mylan Recent Developments

Table 104. Sanofi Company Details

Table 105. Sanofi Business Overview

Table 106. Sanofi Seasonal Affective Disorder Therapeutics Product

Table 107. Sanofi Revenue in Seasonal Affective Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 108. Sanofi Recent Developments

Table 109. Novartis Company Details

Table 110. Novartis Business Overview

Table 111. Novartis Seasonal Affective Disorder Therapeutics Product

Table 112. Novartis Revenue in Seasonal Affective Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 113. Novartis Recent Developments

Table 114. Johnson & Johnson Company Details

Table 115. Johnson & Johnson Business Overview

Table 116. Johnson & Johnson Seasonal Affective Disorder Therapeutics Product

Table 117. Johnson & Johnson Revenue in Seasonal Affective Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 118. Johnson & Johnson Recent Developments

Table 119. Koninklijke Philips Company Details

Table 120. Koninklijke Philips Business Overview

Table 121. Koninklijke Philips Seasonal Affective Disorder Therapeutics Product

Table 122. Koninklijke Philips Revenue in Seasonal Affective Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 123. Koninklijke Philips Recent Developments

Table 124. Beurer GmbH Company Details

Table 125. Beurer GmbH Business Overview

Table 126. Beurer GmbH Seasonal Affective Disorder Therapeutics Product

Table 127. Beurer GmbH Revenue in Seasonal Affective Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 128. Beurer GmbH Recent Developments

Table 129. Lucimed (Luminette) Company Details

Table 130. Lucimed (Luminette) Business Overview

Table 131. Lucimed (Luminette) Seasonal Affective Disorder Therapeutics Product

Table 132. Lucimed (Luminette) Revenue in Seasonal Affective Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 133. Lucimed (Luminette) Recent Developments

Table 134. Research Programs/Design for This Report

Table 135. Key Data Information from Secondary Sources

Table 136. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Seasonal Affective Disorder Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Seasonal Affective Disorder Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Light Therapy (Phototherapy) Features

Figure 4. Medication Features

Figure 5. Others Features

Figure 6. Global Seasonal Affective Disorder Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Seasonal Affective Disorder Therapeutics Market Share by Application: 2023 VS 2030

Figure 8. Hospitals Case Studies

Figure 9. Clinics Case Studies

Figure 10. Others Case Studies

Figure 11. Seasonal Affective Disorder Therapeutics Report Years Considered

Figure 12. Global Seasonal Affective Disorder Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Seasonal Affective Disorder Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Seasonal Affective Disorder Therapeutics Market Share by Region: 2023 VS 2030

Figure 15. Global Seasonal Affective Disorder Therapeutics Market Share by Players in 2023

Figure 16. Global Top Seasonal Affective Disorder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Seasonal Affective Disorder Therapeutics as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Seasonal Affective Disorder Therapeutics Revenue in 2023

Figure 18. North America Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Seasonal Affective Disorder Therapeutics Market Share by Type (2019-2030)

Figure 20. North America Seasonal Affective Disorder Therapeutics Market Share by Application (2019-2030)

Figure 21. North America Seasonal Affective Disorder Therapeutics Market Share by Country (2019-2030)

Figure 22. United States Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Seasonal Affective Disorder Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 25. Europe Seasonal Affective Disorder Therapeutics Market Share by Type (2019-2030)

Figure 26. Europe Seasonal Affective Disorder Therapeutics Market Share by Application (2019-2030)

Figure 27. Europe Seasonal Affective Disorder Therapeutics Market Share by Country (2019-2030)

Figure 28. Germany Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China Seasonal Affective Disorder Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 35. China Seasonal Affective Disorder Therapeutics Market Share by Type (2019-2030)

Figure 36. China Seasonal Affective Disorder Therapeutics Market Share by Application (2019-2030)

Figure 37. Asia Seasonal Affective Disorder Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 38. Asia Seasonal Affective Disorder Therapeutics Market Share by Type (2019-2030)

Figure 39. Asia Seasonal Affective Disorder Therapeutics Market Share by Application (2019-2030)

Figure 40. Asia Seasonal Affective Disorder Therapeutics Market Share by Region (2019-2030)

Figure 41. Japan Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. South Korea Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. China Taiwan Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Seasonal Affective Disorder Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Seasonal Affective Disorder Therapeutics Market Share by Type (2019-2030)

Figure 49. Middle East, Africa, and Latin America Seasonal Affective Disorder Therapeutics Market Share by Application (2019-2030)

Figure 50. Middle East, Africa, and Latin America Seasonal Affective Disorder Therapeutics Market Share by Country (2019-2030)

Figure 51. Brazil Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Mexico Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Turkey Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Israel Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. GCC Countries Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Allergan Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2019-2024)

Figure 58. Pfizer Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2019-2024)

Figure 59. Roche Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2019-2024)

Figure 60. Eli Lily Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2019-2024)

Figure 61. GlaxoSmithKline Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2019-2024)

Figure 62. Teva Pharmaceuticals Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2019-2024)

Figure 63. Bausch Health Companies Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2019-2024)

Figure 64. Mylan Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2019-2024)

Figure 65. Sanofi Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2019-2024)

Figure 66. Novartis Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2019-2024)

Figure 67. Johnson & Johnson Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2019-2024)

Figure 68. Koninklijke Philips Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2019-2024)

Figure 69. Beurer GmbH Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2019-2024)

Figure 70. Lucimed (Luminette) Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2019-2024)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Aesthetic Phototherapy Lamps Market Research Report 2024

Global Bipolar Disorder Therapeutics Drugs Market Insights Forecast to 2030

Global Circadian Rhythm Sleep Disorders Market Insights Forecast to 2030

Mood Disorder Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti depressant Drugs Market

Global Depression Drugs Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Antidepressants Drugs Market Insights Forecast to 2030

Global Jet Lag Therapy Pharmaceuticals Market Insights Forecast to 2030

Global SAD Lamp Market Insights Forecast to 2030

Global Seasonal Affective Disorder Drugs Market Research Report 2024

Global Seasonal Affective Disorder Devices Market Research Report 2024

Bipolar Disorder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Premenstrual Dysphoric Disorder PMDD Market Insights Forecast to 2030

Global Chronic Depressive Personality Disorder Treatment Market Research Report 2024

Global Dysthymia Clinical Trial Market Research Report 2024

Depression Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Circadian Rhythm Sleep Treatment Market Research Report 2025

Global Chronic Fatigue Syndrome Treatment Market Insights Forecast to 2030

Global Sleep Movement Disorder Drug Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions